Objective: The objective of this study was to evaluate the use of head and neck coils through a 3.0T high-resolution magnetic resonance imaging (MRI) scanner to analyze extracranial carotid artery plaque components for composition, nature, stability, wall thickness, and lumen stenosis.
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A Real-World Experience of Drug-Eluting and Non-Drug-Eluting Stents in Lower Extremity Peripheral Arterial Disease Pavel Kibrik, Jesse Victory, Ronak Patel, Matthew Goldstein, Ahmad Alsheekh, Afsha Aurshina, Anil Hingorani, Enrico Ascher. Lutheran Medical Center, Brooklyn, NY Objective: Drug-eluting stents (DESs) have been promoted as an alternative to the traditional non-drug-eluting stents (nDESs) and offer the potential for improved patency rates. However, DESs are more expensive than nDESs, and results comparing these stents outside of clinical trials have been limited.
Methods: A retrospective review was performed of all inpatient infrainguinal lower extremity endovascular procedures between January 2014 and September 2016 that involved stent implantation. Procedures involving the common femoral artery, superficial femoral artery, and above-knee popliteal artery were included. The type of stent, number of stents, length of each stent, and location of stent were recorded for each procedure. End points included stent thrombosis, restenosis, reintervention, and limb loss. Postoperative arterial duplex ultrasound studies were obtained every 3 months to determine stent patency during followup visits through the end of the study period. In-stent stenosis was defined as >60% narrowing on arterial duplex ultrasound. Thrombosis was defined as in-stent occlusion, and limb loss involved only major amputations in the treated extremity. Multivariate analysis, bivariate analysis, and Student two-sample t-test were used to analyze the data.
Results: During the study period, 212 patients underwent at total of 252 procedures. Of this group, 191 procedures met inclusion criteria. The average age of the patients was 73.2 6 11.6 years, 68.6% had hypertension, and 58.1% had diabetes. The most common indication for intervention was claudication (53%), followed by critical limb ischemia (47%). There were 124 procedures that involved only nDESs (LifeStent; Bard Peripheral Vascular, Tempe, Ariz), 46 procedures that involved only DESs (Zilver; Cook Medical, Bloomington, Ind), and 21 procedures that involved both DESs and nDESs (mixed). Comparison of nDESs and DESs showed the rate of thrombosis (11.1% vs 16.7%; P ¼ .81), reintervention (13.7% vs 14.3%; P ¼ 1.0), and limb loss (9.7% vs 0.0%; P ¼ .38) to be equivalent between the groups. The 6-month primary patency rates for nDESs and DESs (41.9% vs 40.0%; P ¼ 1.0) were also equivalent. On average, the average lengths of nDESs were longer than DESs (19.2 6 14.3 cm vs 11.4 6 5.7 cm; P < .0001). Mixed nDES and DES results showed a 33% restenosis rate, 7.1% thrombosis rate, and no limb loss. The mixed stent patency rate at 6 months was 28.6%. There were no statistical differences between the nDES and DES groups with respect to sex, age, laterality, diabetes mellitus, coronary artery disease, gangrene, ulcers, hyperlipidemia, atrial fibrillation, deep venous thrombosis, claudication, ipsilateral bypass, restenosis, thrombosis, limb loss, or ipsilateral amputation. Bivariate analysis showed a higher incidence of hypertension for nDES patients (P ¼ .001).
Conclusions: In this retrospective analysis from one institution, the use of an nDES or DES did not result in a statistically significant difference in the rate of thrombosis, restenosis, ipsilateral reintervention, or ipsilateral amputation during a 2-year period in the common femoral artery, superficial femoral artery, and above-knee popliteal artery.
Author Disclosures: A. Alsheekh: Nothing to disclose; E. Ascher: Nothing to disclose; A. Aurshina: Nothing to disclose; M. Goldstein: Nothing to disclose; A. Hingorani: Nothing to disclose; P. Kibrik: Nothing to disclose; R. Patel: Nothing to disclose; J. Victory: Nothing to disclose. Objective: The objective of this study was to describe and to evaluate the feasibility, safety, and efficacy of retrograde arterial recanalization of infrainguinal chronic total occlusions (CTOs) in the office-based laboratory (OBL) setting.
IP197.

Distal Retrograde Access for Infrainguinal
Methods: A prospective observational evaluation of consecutive patients who underwent endovascular interventions for lower extremity CTOs in the OBL setting from January 2013 to November 2017 by a single surgeon was performed. In all cases, access across lesions was first attempted by an antegrade, contralateral approach. If crossing was unsuccessful, a retrograde popliteal or tibial retrograde approach was used. After successful crossing, the procedure was converted to an antegrade approach and endovascular therapy was delivered. Characteristics of the patients, CTO location, procedure performed, procedural time, costs, contrast material dose, anticoagulation dose, and radiation dose were recorded. Complications were also documented by phone on postprocedure day 1 and in a clinic visit 10 to 14 days after the procedure. Three groups were used for comparison: group 1, standard antegrade approach for femoropopliteal CTOs; group 2, standard antegrade approach for tibial CTOs; and group 3, retrograde approach for femoropopliteal and tibial CTOs.
Results: There were 237 patients treated for infrainguinal arterial CTOs in the study period. In 38 (16%), the lesions were not able to be crossed by using an antegrade or retrograde approach. A successful antegrade approach was used in 186 of the patients; 69% (group 1, n ¼ 129 patients) had CTOs of the femoropopliteal arteries, and 31% (group 2, n ¼ 57 patients) had tibial CTOs. A total of 13 patients (6.5%, group 3) were treated by a retrograde distal approach. No demographic differences in the three groups were seen (mean age, 75.4 years; 66% male). All groups had similar prevalence of comorbidities except diabetes, which was more prevalent in group 2 (P ¼ .01). Group 3 patients received a higher contrast material dose than groups 1 and 2 (P ¼ .01). However, patients in groups 1 and 2 received similar contrast material doses. Group 3 patients had the highest operative time and cost of treatment, followed by group 1 and then group 2 (P ¼ .01). Three femoral pseudoaneurysms (two requiring hospitalization) were noted in group 1 and two (both needing hospital care) in group 2. No complications were recorded in patients in group 3.
Conclusions: Retrograde access is required in 7% of patients afflicted by infrainguinal CTOs successfully treated in the OBL setting. Although the operative times, costs, and radiation and contrast material doses are higher, this method represents a safe and effective method for the crossing of CTO infrainguinal lesions in an ambulatory venue.
Author Disclosures: C. Harris: Nothing to disclose; S. Jhajj: Nothing to disclose; N. Labropoulos: Nothing to disclose; L. R. Leon: Nothing to disclose; J. Pacanowski: Nothing to disclose; V. Pandit: Nothing to disclose. Objective: Although the effect of body mass index on the treatment of infrainguinal peripheral arterial disease (PAD) has been analyzed, outcomes of patients on the high end of the spectrum of morbid obesity (MO; body mass index >40) and superobesity (SO) are unclear. Our goal was to analyze perioperative outcomes of infrainguinal PAD after lower extremity bypass (LEB) and peripheral vascular interventions (PVI) in this population of patients.
IP199. Outcomes After Open and Endovascular Treatment of Infrainguinal Occlusive Disease in Morbidly Obese and Superobese Patients
Methods: The Vascular Quality Initiative was reviewed for all infrainguinal PAD interventions from 2010 to 2017. Patient and case details were recorded. Multivariable analysis was used to analyze outcomes.
Results: We identified 30,389 LEB cases (69.8% nonobese, 27.1% obese, 2.8% MO, 0.33% SO) and 84,649 PVI cases (67.9% nonobese, 28.1% obese, 3.5% MO, 0.52% SO). For LEB and PVI, MO and SO patients were younger, more often female, less often with smoking history, more often on Medicaid, and more often ambulatory; they more often had diabetes, end-stage renal disease, and congestive heart failure, with fewer previous inflow procedures (P < .05 for all). LEB and PVI interventions in MO and SO patients were less often elective and more often for tissue loss. For LEB, MO and SO patients more often had greater saphenous vein used as conduit and had popliteal artery origin grafts (P < .05). In PVI, MO and SO patients more often had tibial interventions (P < .05). Multivariable analysis showed that MO and SO after LEB were not associated with increased perioperative cardiac complications, return to operating room, primary patency, and mortality (Table) . MO was associated with increased surgical site infection. Multivariable analysis showed that MO and SO after LEB were not associated with periprocedural access site hematoma, access site stenosis/ occlusion, and mortality (Table) .
Conclusions: MO and SO were not independently associated with increased major adverse outcomes after LEB and PVI, aside from surgical site infections after LEB. Overall, MO and SO patients have more comorbidities and have more advanced presentation. MO and SO alone should not deter appropriate revascularization. Objective: Lower extremity fasciotomies after reperfusion in patients with acute lower extremity ischemia are occasionally performed prophylactically to reduce the risk of limb loss due to compartment syndrome, yet there are few data to support this practice. In this study, we compared amputation rates and other outcomes after emergent lower extremity embolectomy with and without concurrent fasciotomy.
Methods: A retrospective analysis was performed using prospectively collected data in the National Surgical Quality Improvement Program for patients undergoing emergent arterial lower extremity embolectomy between 2011 and 2016. Preoperative characteristics and 30-day outcomes were compared for patients who underwent lower extremity embolectomy with and without fasciotomy at the index operation. Multivariable regression was performed to establish independent predictors of outcomes. 
